Can you provide the last earnings date for REPLIGEN CORP?
REPLIGEN CORP (RGEN) last reported earnings on 2/24/2026.
NASDAQ:RGEN • US7599161095
Past quarterly earnings results for REPLIGEN CORP (RGEN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.49 | 0.45 | 9.25% | 11.36% | 197.913M | 196.77M | 0.58% | 18.12% |
| Q3 2025 | 0.46 | 0.43 | 7.78% | 6.98% | 188.805M | 184.97M | 2.07% | 21.94% |
| Q2 2025 | 0.37 | 0.40 | -6.83% | 12.12% | 182.366M | 178.52M | 2.15% | 18.36% |
| Q1 2025 | 0.39 | 0.35 | 10.73% | 39.29% | 169.172M | 167.11M | 1.23% | 11.80% |
| Q4 2024 | 0.44 | 0.42 | 5.21% | 33.33% | 167.547M | 171.02M | -2.03% | 7.58% |
| Q3 2024 | 0.43 | 0.34 | 25.89% | 86.96% | 154.834M | 156.29M | -0.93% | 9.66% |
| Q2 2024 | 0.33 | 0.33 | -0.80% | -37.74% | 154.073M | 157.2M | -1.99% | -3.20% |
| Q1 2024 | 0.28 | 0.31 | -9.00% | -56.25% | 151.31M | 153.06M | -1.14% | -17.16% |
| Q4 2023 | 0.33 | 0.33 | -0.62% | -51.47% | 155.743M | 158.49M | -1.73% | -16.63% |
| Q3 2023 | 0.23 | 0.17 | 35.96% | -70.13% | 141.192M | 143.46M | -1.58% | -29.65% |
| Q2 2023 | 0.53 | 0.48 | 9.34% | -41.76% | 159.169M | 169.24M | -5.95% | -23.33% |
| Q1 2023 | 0.64 | 0.60 | 6.89% | -30.43% | 182.66M | 185.06M | -1.30% | -11.50% |
| Q4 2022 | 0.68 | 0.59 | 15.49% | -16.05% | 186.8M | 188.25M | -0.77% | 0.16% |
| Q3 2022 | 0.77 | 0.69 | 11.01% | -1.28% | 200.7M | 195.33M | 2.75% | 12.63% |
| Q2 2022 | 0.91 | 0.73 | 24.49% | 15.19% | 207.6M | 193.12M | 7.50% | 27.36% |
| Q1 2022 | 0.92 | 0.73 | 25.27% | 35.29% | 206.4M | 189.19M | 9.10% | 44.54% |
| Q4 2021 | 0.81 | 0.66 | 22.41% | 55.77% | 186.5M | 182.88M | 1.98% | 71.73% |
| Q3 2021 | 0.78 | 0.65 | 20.19% | 95.00% | 178.2M | 167.25M | 6.55% | 89.37% |
| Q2 2021 | 0.79 | 0.53 | 47.88% | 88.10% | 163M | 147.13M | 10.79% | 86.29% |
| Q1 2021 | 0.68 | 0.43 | 57.79% | 112.50% | 142.8M | 119.35M | 19.65% | 87.65% |
| Q4 2020 | 0.52 | 0.31 | 66.47% | - | 108.6M | 95.754M | 13.42% | - |
| Q3 2020 | 0.40 | 0.28 | 41.94% | - | 94.1M | 88.178M | 6.72% | - |
| Q2 2020 | 0.42 | 0.28 | 50.12% | - | 87.5M | 79.948M | 9.45% | - |
| Q1 2020 | 0.32 | 0.23 | 41.80% | - | 76.1M | 72.612M | 4.80% | - |
Notes
REPLIGEN CORP (RGEN) last reported earnings on 2/24/2026.
REPLIGEN CORP (RGEN) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, REPLIGEN CORP (RGEN) has beaten EPS estimates in 3 out of 4 releases.